Milestone Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 6 analysts polled by S&P Global, Milestone Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $6.33. The average 1-year stock price forecast is 342.66% higher than the current stock price, while the lowest is $2.00 (+39.86%) and the highest is $8.00 (+459.44%).

Price Target: $6.33 (+342.66%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$2.00	$6.33	$7.00	$8.00
Change	+39.86%	+342.66%	+389.51%	+459.44%

Analyst Ratings

The average analyst rating for Milestone Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	3	3	3	3	3	2
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	4	4	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Mohit Bansal Wells Fargo	Wells Fargo	Buy Maintains $8 → $7	Buy	Maintains	$8 → $7	+389.51%	May 14, 2026
Brandon Folkes HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $8	Strong Buy	Reiterates	$8	+459.44%	Jan 6, 2026
Mohit Bansal Wells Fargo	Wells Fargo	Buy Maintains $4 → $8	Buy	Maintains	$4 → $8	+459.44%	Dec 16, 2025
Ritu Baral TD Cowen	TD Cowen	Hold → Strong Buy Upgrades $8	Hold → Strong Buy	Upgrades	$8	+459.44%	Dec 15, 2025
Brandon Folkes HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $5 → $8	Strong Buy	Maintains	$5 → $8	+459.44%	Dec 15, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

6.64M

from 1.55M

329.62%

from 1.55M

Revenue Next Year

30.04M

from 6.64M

352.26%

from 6.64M

EPS This Year

-0.79

from -0.75

EPS Next Year

-1.07

from -0.79

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	15.00M	5.00M	1.00M	-	1.55M	6.64M	30.04M
Revenue Growth	-	-66.67%	-80.00%	-	-	329.62%	352.26%
EPS	-1.02	-1.38	-1.39	-0.67	-0.75	-0.79	-1.07
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	8	8

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	8.6M	42.0M
Avg	6.6M	30.0M
Low	3.9M	20.6M

Revenue Growth

Revenue Growth	2026	2027
High	456.9%	532.3%
Avg	329.6%	352.3%
Low	153.6%	209.8%

EPS Forecast

EPS	2026	2027
High	-0.13	-0.70
Avg	-0.79	-1.07
Low	-1.53	-1.72

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.